Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHYLPREDNISOLONE Cause Hypokalaemia? 381 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 381 reports of Hypokalaemia have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.6% of all adverse event reports for METHYLPREDNISOLONE.

381
Reports of Hypokalaemia with METHYLPREDNISOLONE
0.6%
of all METHYLPREDNISOLONE reports
23
Deaths
225
Hospitalizations

How Dangerous Is Hypokalaemia From METHYLPREDNISOLONE?

Of the 381 reports, 23 (6.0%) resulted in death, 225 (59.1%) required hospitalization, and 57 (15.0%) were considered life-threatening.

Is Hypokalaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 381 reports have been filed with the FAERS database.

What Other Side Effects Does METHYLPREDNISOLONE Cause?

Off label use (10,364) Drug ineffective (9,959) Product use in unapproved indication (4,115) Condition aggravated (3,784) Headache (3,419) Fatigue (3,250) Pyrexia (3,226) Pain (3,165) Nausea (3,105) Pneumonia (3,006)

What Other Drugs Cause Hypokalaemia?

FUROSEMIDE (2,503) HYDROCHLOROTHIAZIDE (1,152) CARBOPLATIN (1,118) PREDNISONE (967) DEXAMETHASONE (876) CYCLOPHOSPHAMIDE (864) OMEPRAZOLE (851) RITUXIMAB (822) AMLODIPINE (815) PANTOPRAZOLE (811)

Which METHYLPREDNISOLONE Alternatives Have Lower Hypokalaemia Risk?

METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE METHYLPREDNISOLONE vs METILDIGOXIN METHYLPREDNISOLONE vs METOCLOPRAMIDE METHYLPREDNISOLONE vs METOLAZONE

Related Pages

METHYLPREDNISOLONE Full Profile All Hypokalaemia Reports All Drugs Causing Hypokalaemia METHYLPREDNISOLONE Demographics